Friday, 25 May 2018

You are here

The RheumNow Week in Review – Vitamin D Snark Report (4.20.18)

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.  A second life for Syk kinase, Vitamin D talk, VTE, regulatory hearings and the Lupus clinic edge.

  1. Fostamatinib, a spleen tyrosine kinase (Syk)inhibitor, that failed in #RA, has been FDA approved for use in adult with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. The drug will be called Tavalisse. http://bit.ly/2K2zpyG
  2. ACTIVExtend study shows that 9mos of abaloparatide followed by 2 yrs of alendronate is better for BMD and Fx rates than abaloparatide or alendronate alone. https://t.co/amYAsxnwhe
  3. Medscapes annual report on MD salararies shows a pay increased of 9% to $257,000 (the range in change was +16% to a -9% for general surgeons). https://t.co/TN70M3nn0K
  4. IGRA are specific for M.Tbc but there are few NTM (nontuberculous mycobacteria) that can give a +QFT; M. Bovis, M. Africans, M. kansasii, M.Szulgai, M. marinum, M.gordonae. These have ESAT & CFP Ags. https://t.co/yFWsCb5ncT
  5. 2996 HIV+ patients on HRT finds 113 w/ Rheumatic disease, lead by AVN 39 (1.3%), psoriasis 28 (1%), RA 7, PsA 6, & SLE 6pts. HIV Males 1.7 times more likely to have a rheum Dz. Hep C incr the risk of RD. RD Risk in HIV+ appears same as gen population. https://t.co/32PiLEeKgI
  6. Lupus care provided by a Lupus specialty vs General Rheumatology (GRC) shows LC w/ better quality measures [86% vs 70%] w/ better APL testing, DXA, steroid sparing , ACE inhibitor use Moderate correlation between the MDs #SLE patients and QM performance https://t.co/HeHZgkA0Gv
  7. Study of 1181 Systemic Sclerosis pts finds 3.4% w/ hx of VTE events= VTE incidence of 2.7 per 1000 pt-yrs (equal to general population). Risk factors for VTE were PAH, peripheral arterial disease, Scl-70+, anticardiolipin Abs (OR 2.45-5.7) https://t.co/AgBb7tGvGh
  8. What drives VTE risk in Rheumatology Clinic? Surgery, inflammation, obesiy, smoking, drugs or Cancer? RHEUMS ONLY vote here--> https://t.co/rmilEeZthL
  9. EMA will have a hearing on June 13th on the safety of quinolones. https://t.co/14r8fQtpcB 
  10. OMI! Low Vitamin D is ALSO associated with an increase risk of noninfectious uveitis, primarily in blacks - if only giving vitamin D could fix the disease its associated with ! https://t.co/Ao41s8YHjG
  11. UNBELIEVABLE. NEWS FLASH.. Vitamin D again linked to something, this time a greater risk of diabetes. Take the vitamin D and a few marshmallows. http://bit.ly/2HfjGue
  12. USPSTF Recommendations on Vitamin D, Calcium Supplementation to Prevent Fractures  
  13. Kineret Approved for Still's Disease in EU 
  14. Shared Epitope - Smoking Pathogenic Link Clarified  

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Rheumatologists' Comments

Fantastic ! Thanks for these short news of rheumatology relavent .I have a question : can Osteoporosis be regarded as an autoimmune disease ? Because in on study at HIV -infected patients after 48 wks Treatment with ART regimen despite decline of BMD &TBS , BMSi measured by Osteoprobe (RPI Technology )increased by 7% !
Fantastic ! Thanks for these short news of rheumatology relavent .I have a question : can Osteoporosis be regarded as an autoimmune disease ? Because in one study on the HIV -infected patients after 48 wks Treatment with ART regimen despite decline of BMD &TBS , BMSi measured by Osteoprobe (RPI Technology )increased by 7% !

More Like This

The RheumNow Week in Review – Methotrexate CIRT Study (5.25.18)

Dr. Jack Cush reviews this past weeks news from RheumNow.com - the risk of Cutaneous and Systemic LE, increasing flu vaccination, higher risk of VTE, MPO predictions, new drug for GIOP and CIRT - MTX in cardiovascular risk patients.

ACR Leaders Lobby Capitol Hill for Help on Rising Costs and Access Barriers in Arthritis Care

Rheumatologists and rheumatology health professionals convened on Capitol Hill this week to urge legislative action on pressing policy issues affecting rheumatology care during the American College of Rheumatology’s Advocacy Leadership Conference, held May 16 -17, 2018 in Washington, D.C.

The RheumNow Week in Review – Modifiable Behavior (5.18.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  He discusses opioids, new approval for polyarticular JIA, running and osteoarthritis, and modifiable behaviors that influence outcomes. 

The RheumNow Week in Review - Nonadherence and Astronomic Costs (5.11.18)

Dr. Jack Cush reviews highlights, news and journal articles from the past week on RheumNow.com.

Rising Need for Weight Loss Counseling in Arthritic Patients

The CDC's May 4th MMWR reports that from 2002 to 2014, the prevalence of health care provider counseling for weight loss among adults with arthritis and overweight or obesity increased by 10% (from 35% to 45%).

Among the 54.4 million adults with doctor-diagnosed arthritis in the United States, 32.7% are overweight and 38.1% are obese. Moreover obesity is more prevalent among persons with arthritis than among those who do not have arthritis.